Pulsify Medical develops monitoring technology for healthcare applications. The company focuses on providing solutions that track physiological data for improved patient oversight. Their technology aims to enhance the efficiency and accuracy of remote and in-clinic patient monitoring.
Funding
$9.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cardiac monitoring in critical care settings relies on intermittent assessments, which may not capture rapid changes in cardiac function. Continuous, non-invasive monitoring is needed to promptly detect and manage hemodynamic instability in ICU patients.
Solution
Pulsify Medical offers a flexible, wearable ultrasound patch for continuous cardiac monitoring in the ICU. The patch utilizes an innovative ultrasound sensor to directly track heart function non-invasively. By continuously capturing and transmitting real-time data on key cardiac parameters, the Pulsify patch enables healthcare providers to closely monitor cardiac performance and make timely clinical decisions. The device aims to improve patient outcomes by providing a more comprehensive and responsive approach to cardiac monitoring in critical care.
Target Audience
The primary target audience includes healthcare providers in intensive care units (ICUs) and intermediate care units (IMCs) who require continuous and precise cardiac monitoring for critically ill patients.
Features
- Flexible ultrasound patch that adheres to the patient's chest
- Continuous, non-invasive monitoring of cardiac output, stroke volume, and ejection fraction
- Real-time data transmission to ICU monitors
- Wireless and adaptable to each patient’s unique needs